IL-27 induces a set of proteins broadly overlapping with those induced by IFN-γ [31] and shares several anti-tumor functions in common with IFNs, including anti-angiogenic activities [32], induction of HLA-class I molecule expression [33,34,35], and anti-proliferative activity on cancer cells [36,37]. The gene discussed is IFNG; the disease is neoplasm.